Form 4: Concentra Group Holdings Director Reports Share Acquisition Following Spinoff

Robert A. Ortenzio, a director at Concentra Group Holdings, reports the acquisition of shares due to a pro-rata distribution from Select Medical Holdings Corporation.

Summary

• Robert A. Ortenzio, a director of Concentra Group Holdings Parent, Inc., has reported the acquisition of shares of common stock.
• The acquisition occurred on November 25, 2024, as a result of a pro-rata distribution of Concentra shares by Select Medical Holdings Corporation to its shareholders.
• Mr. Ortenzio acquired a total of 5,513,054 shares directly and 4,781,330 shares indirectly through various trusts.
• The shares were acquired at a price of $0, reflecting the distribution nature of the transaction.
• This transaction is voluntarily reported despite an exemption provided by Rule 16a-9.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction following a corporate spin-off. The acquisition of shares by a director is a positive sign, but the transaction itself is expected and does not indicate any significant positive or negative sentiment.

Positives

• The acquisition of shares by a director indicates confidence in the newly spun-off company.
• The pro-rata distribution ensures existing shareholders of Select Medical Holdings also have a stake in Concentra Group Holdings.

Risks

• The document does not detail any risks associated with the transaction.

Industry Context

This transaction is a result of a corporate spin-off, a common strategy for companies to unlock value by separating different business units. The distribution of shares to existing shareholders ensures a broad base of ownership for the new entity.

Comparison to Industry Standards

• Corporate spin-offs are a common practice, with companies like Hewlett Packard Enterprise and VMWare recently completing similar transactions.
• The pro-rata distribution of shares is a standard method for ensuring existing shareholders receive a stake in the new entity.
• Form 4 filings are a standard requirement for reporting changes in beneficial ownership by company insiders, such as directors.

Stakeholder Impact

• Shareholders of Select Medical Holdings received shares in Concentra Group Holdings, impacting their investment portfolio.
• The transaction establishes a new ownership structure for Concentra Group Holdings.

Key Dates

Keywords

Concentra Group Holdings, Robert A. Ortenzio, share acquisition, pro-rata distribution, Select Medical Holdings, Form 4, spinoff, director